417 related articles for article (PubMed ID: 19493611)
41. Dysferlin homozygous mutation G1418D causes limb-girdle type 2B in a Mexican family.
Rosas-Vargas H; Gómez-Díaz B; Ruano-Calderón L; Fernández-Valverde F; Roque-Ramírez B; Portillo-Bobadilla T; Ordoñez-Razo RM; Minauro-Sanmiguel F; Coral-Vázquez R
Genet Test; 2007; 11(4):391-6. PubMed ID: 18294055
[TBL] [Abstract][Full Text] [Related]
42. Identification of a dysferlin gene mutation in a Korean case with Miyoshi myopathy.
Oh SH; Kim TS; Choi YC
Yonsei Med J; 2004 Oct; 45(5):927-30. PubMed ID: 15515206
[TBL] [Abstract][Full Text] [Related]
43. Case report of an adolescent girl with limb-girdle muscular dystrophy type 2B - the usefulness of muscle protein immunostaining in the diagnosis of dysferlinopathies.
Szymanska S; Rokicki D; Karkucinska-Wieckowska A; Szymanska-Debinska T; Ciara E; Ploski R; Grajkowska W; Pronicki M
Folia Neuropathol; 2014; 52(4):452-6. PubMed ID: 25574751
[TBL] [Abstract][Full Text] [Related]
44. Defective myotilin homodimerization caused by a novel mutation in MYOT exon 9 in the first Japanese limb girdle muscular dystrophy 1A patient.
Shalaby S; Mitsuhashi H; Matsuda C; Minami N; Noguchi S; Nonaka I; Nishino I; Hayashi YK
J Neuropathol Exp Neurol; 2009 Jun; 68(6):701-7. PubMed ID: 19458539
[TBL] [Abstract][Full Text] [Related]
45. Scapuloperoneal syndrome type Kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P.
Walter MC; Reilich P; Huebner A; Fischer D; Schröder R; Vorgerd M; Kress W; Born C; Schoser BG; Krause KH; Klutzny U; Bulst S; Frey JR; Lochmüller H
Brain; 2007 Jun; 130(Pt 6):1485-96. PubMed ID: 17439987
[TBL] [Abstract][Full Text] [Related]
46. A mutation in the fast skeletal muscle troponin I gene causes myopathy and distal arthrogryposis.
Kimber E; Tajsharghi H; Kroksmark AK; Oldfors A; Tulinius M
Neurology; 2006 Aug; 67(4):597-601. PubMed ID: 16924011
[TBL] [Abstract][Full Text] [Related]
47. Comparing clinical data and muscle imaging of DYSF and ANO5 related muscular dystrophies.
Ten Dam L; van der Kooi AJ; Rövekamp F; Linssen WH; de Visser M
Neuromuscul Disord; 2014 Dec; 24(12):1097-102. PubMed ID: 25176504
[TBL] [Abstract][Full Text] [Related]
48. Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype.
Illa I; Serrano-Munuera C; Gallardo E; Lasa A; Rojas-García R; Palmer J; Gallano P; Baiget M; Matsuda C; Brown RH
Ann Neurol; 2001 Jan; 49(1):130-4. PubMed ID: 11198284
[TBL] [Abstract][Full Text] [Related]
49. Dysferlin mutation in a Chinese pedigree with Miyoshi myopathy.
Shunchang S; Fan Q; Huacheng W; Leturcq F; Yongjian S; Bingfeng Z; Wen Y; Deburgrave N
Clin Neurol Neurosurg; 2006 Jun; 108(4):369-73. PubMed ID: 16023782
[TBL] [Abstract][Full Text] [Related]
50. Dysferlin and the plasma membrane repair in muscular dystrophy.
Bansal D; Campbell KP
Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
[TBL] [Abstract][Full Text] [Related]
51. Two common mutations (p.Gln832X and c.663+1G>C) account for about a third of the DYSF mutations in Korean patients with dysferlinopathy.
Park YE; Kim HS; Lee CH; Nam TS; Choi YC; Kim DS
Neuromuscul Disord; 2012 Jun; 22(6):505-10. PubMed ID: 22297152
[TBL] [Abstract][Full Text] [Related]
52. Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome.
Chrobáková T; Hermanová M; Kroupová I; Vondrácek P; Maríková T; Mazanec R; Zámecník J; Stanek J; Havlová M; Fajkusová L
Neuromuscul Disord; 2004 Oct; 14(10):659-65. PubMed ID: 15351423
[TBL] [Abstract][Full Text] [Related]
53. Miyoshi myopathy patients with novel 5' splicing donor site mutations showed different dysferlin immunostaining at the sarcolemma.
Saito A; Higuchi I; Nakagawa M; Saito M; Hirata K; Suehara M; Yoshida Y; Takahashi T; Aoki M; Osame M
Acta Neuropathol; 2002 Dec; 104(6):615-20. PubMed ID: 12410383
[TBL] [Abstract][Full Text] [Related]
54. Proteomic investigation of the molecular pathophysiology of dysferlinopathy.
De Palma S; Morandi L; Mariani E; Begum S; Cerretelli P; Wait R; Gelfi C
Proteomics; 2006 Jan; 6(1):379-85. PubMed ID: 16302276
[TBL] [Abstract][Full Text] [Related]
55. Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B.
Takahashi T; Aoki M; Suzuki N; Tateyama M; Yaginuma C; Sato H; Hayasaka M; Sugawara H; Ito M; Abe-Kondo E; Shimakura N; Ibi T; Kuru S; Wakayama T; Sobue G; Fujii N; Saito T; Matsumura T; Funakawa I; Mukai E; Kawanami T; Morita M; Yamazaki M; Hasegawa T; Shimizu J; Tsuji S; Kuzuhara S; Tanaka H; Yoshioka M; Konno H; Onodera H; Itoyama Y
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):433-40. PubMed ID: 23243261
[TBL] [Abstract][Full Text] [Related]
56. Consequences of mutations within the C terminus of the FHL1 gene.
Schoser B; Goebel HH; Janisch I; Quasthoff S; Rother J; Bergmann M; Müller-Felber W; Windpassinger C
Neurology; 2009 Aug; 73(7):543-51. PubMed ID: 19687455
[TBL] [Abstract][Full Text] [Related]
57. Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J.
Udd B; Vihola A; Sarparanta J; Richard I; Hackman P
Neurology; 2005 Feb; 64(4):636-42. PubMed ID: 15728284
[TBL] [Abstract][Full Text] [Related]
58. Dysferlin mutation analysis in a group of Italian patients with limb-girdle muscular dystrophy and Miyoshi myopathy.
Kawabe K; Goto K; Nishino I; Angelini C; Hayashi YK
Eur J Neurol; 2004 Oct; 11(10):657-61. PubMed ID: 15469449
[TBL] [Abstract][Full Text] [Related]
59. Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/Miyoshi Myopathy necessitates mutational screen for diagnosis [corrected].
Nilsson MI; Laureano ML; Saeed M; Tarnopolsky MA
Muscle Nerve; 2013 May; 47(5):740-7. PubMed ID: 23519732
[TBL] [Abstract][Full Text] [Related]
60. Dysferlinopathy in Iran: Clinical and genetic report.
Fatehi F; Nafissi S; Urtizberea JA; Blanck-Labelle V; Lévy N; Krahn M; Dbouk MB; Attarian S
J Neurol Sci; 2015 Dec; 359(1-2):256-9. PubMed ID: 26671124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
